Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2014; 20(20): 6329-6335
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6329
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6329
Table 4 Hypermethylated SFRP2 and WIF-1 genes and fecal occult blood test for the detection of colorectal tumors n (%)
| Group | n | HypermethylatedSFRP2andWIF-1 | Fecal occult blood test | Pvalue |
| CRC | 48 | 39 (81.3) | 27 (56.3) | 0.008 |
| Dukes A-B | 27 | 22 (81.5) | 14 (51.9) | 0.021 |
| Dukes A | 7 | 6 (85.7) | 2 (28.5) | 0.031 |
| Dukes B | 20 | 16 (80.0) | 12 (60.0) | 0.168 |
| Dukes C-D | 21 | 17 (81.0) | 13 (61.9) | 0.170 |
| Dukes C | 14 | 10 (71.4) | 8 (57.1) | 0.430 |
| Dukes D | 7 | 7 (100) | 5 (71.4) | 0.127 |
| Adenoma | 35 | 23 (65.7) | 9 (25.7) | < 0.001 |
| Advanced | 15 | 12 (80.0) | 5 (33.3) | 0.010 |
| Non-advanced | 20 | 11 (55.0) | 4 (20.0) | 0.022 |
| Hyperplastic polyp | 32 | 8 (25.0) | 5 (15.6) | 0.351 |
| Normal control | 30 | 1 (3.3) | 1 (3.3) | 1.000 |
- Citation: Zhang H, Zhu YQ, Wu YQ, Zhang P, Qi J. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer. World J Gastroenterol 2014; 20(20): 6329-6335
- URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6329.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i20.6329